HaploPharma is a Japanese biotech company established in 2004.
We are focusing on advanced Pharmacogenomics and are developing innovative platform technologies for pharmaceutical R&D and medical diagnostics.

ExpressGenotyping logo Pro 500

xpressGenotypingis our innovative technology to discover critical pharmacogenetic polymorphisms and to provide genetic markers to diagnose them. ExpressGenotyping determines the genome-wide level of gene expression, discovers expression imbalance of polymorphic alleles, and identifies corresponding marker SNPs.

This will provide you with genetic biomarkers for the prediction of individual drug response (drug efficacy and adverse events) in pharmaceutical development and clinical application.

Our groundbreaking technology will enable you to discover biomarkers in an earlier stage of drug development and with a much smaller number of samples than conventional approaches, thus creating valuable information that should considerably improve the efficiency and reduce the risk of drug development.